The neutrophil to lymphocyte ratio (NLR) is a simple and cost-effective biomarker calculated by dividing the number of neutrophils by the number of lymphocytes in a blood sample. This ratio is gaining attention in the medical field, particularly in oncology, for its potential to predict outcomes and monitor disease progression.
